134 related articles for article (PubMed ID: 7535073)
1. Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).
Ono M
Eur J Cancer; 1994; 30A Suppl 3():S7-11. PubMed ID: 7535073
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency.
Nissen C
Eur J Cancer; 1994; 30A Suppl 3():S12-4. PubMed ID: 7535065
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
6. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation interference on RhoA activation: focus on G-CSF.
Mattii L; Battolla B; Azzarà A; D'Urso G; Montali U; Petrini M
Leuk Res; 2011 Feb; 35(2):265-7. PubMed ID: 20573400
[TBL] [Abstract][Full Text] [Related]
8. Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE.
Ribarska JT; Jolevska ST; Panovska AP; Dimitrovska A
Acta Pharm; 2008 Jun; 58(2):199-206. PubMed ID: 18515229
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor: its potential role in infectious disease.
Hartung T
AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
[TBL] [Abstract][Full Text] [Related]
10. [A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].
Takeshita A; Ohno R; Hirashima K; Toyama K; Okuma M; Saito H; Ikeda Y; Tomonaga M; Asano S
Rinsho Ketsueki; 1995 Jun; 36(6):606-14. PubMed ID: 7543956
[TBL] [Abstract][Full Text] [Related]
11. Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor.
Holloway CJ
Eur J Cancer; 1994; 30A Suppl 3():S2-6. PubMed ID: 7535067
[TBL] [Abstract][Full Text] [Related]
12. Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.
Linch DC; Scarffe H; Proctor S; Chopra R; Taylor PR; Morgenstern G; Cunningham D; Burnett AK; Cawley JC; Franklin IM
Bone Marrow Transplant; 1993 Apr; 11(4):307-11. PubMed ID: 7683552
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise.
Morstyn G; Foote M; Perkins D; Vincent M
Stem Cells; 1994; 12 Suppl 1():213-27; discussion 227-8. PubMed ID: 7535147
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in children.
Donadieu J; Boutard P; Tchernia G; Oster G; Gordon-Smith EC; Philippe N; Le Gall E; Nivelon JL; Dopfer P; Babin-Boilletot A
Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):441-8. PubMed ID: 7538658
[TBL] [Abstract][Full Text] [Related]
15. Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.
Frampton JE; Yarker YE; Goa KL
Drugs; 1995 May; 49(5):767-93. PubMed ID: 7541335
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production.
Decleva E; Cramer R; Zabucchi G
Int J Tissue React; 1995; 17(5-6):191-8. PubMed ID: 8835629
[TBL] [Abstract][Full Text] [Related]
17. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
Höglund M
Med Oncol; 1998 Dec; 15(4):229-33. PubMed ID: 9951685
[TBL] [Abstract][Full Text] [Related]
18. Human granulocyte colony-stimulating factor (rHuG-CSF) for treatment of neutropenia in Shwachman syndrome.
Ventura A; Dragovich D; Luxardo P; Zanazzo G
Haematologica; 1995; 80(3):227-9. PubMed ID: 7545636
[TBL] [Abstract][Full Text] [Related]
19. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
[TBL] [Abstract][Full Text] [Related]
20. In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trial.
Fossat C; Stoppa AM; Sainty D; Blaise D; Viens P; Bayssas M; Yver A; Juhan-Vague I; Maraninchi D
Stem Cells; 1994 May; 12(3):322-8. PubMed ID: 7521242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
